REFERENCES

1. Mehta A, Belmatoug N, Bembi B, et al. Exploring the patient journey to diagnosis of Gaucher disease from the perspective of 212 patients with Gaucher disease and 16 Gaucher expert physicians. Mol Genet Metab. 2017;122:122-9.

2. Di Rocco M, Andria G, Deodato F, Giona F, Micalizzi C, Pession A. Early diagnosis of Gaucher disease in pediatric patients: proposal for a diagnostic algorithm. Pediatr Blood Cancer. 2014;61:1905-9.

3. Mistry PK, Cappellini MD, Lukina E, et al. A reappraisal of Gaucher disease-diagnosis and disease management algorithms. Am J Hematol. 2011;86:110-5.

4. Nishimura S, Ma C, Sidransky E, Ryan E. Obstacles to early diagnosis of Gaucher disease. Ther Clin Risk Manag. 2025;21:93-101.

5. Elstein D, Belmatoug N, Bembi B, et al. Twelve years of the Gaucher Outcomes Survey (GOS): insights, achievements, and lessons learned from a global patient registry. J Clin Med. 2024;13:3588.

6. Mistry PK, Sadan S, Yang R, Yee J, Yang M. Consequences of diagnostic delays in type 1 Gaucher disease: the need for greater awareness among hematologists-oncologists and an opportunity for early diagnosis and intervention. Am J Hematol. 2007;82:697-701.

7. Mehta A, Kuter DJ, Salek SS, et al. Presenting signs and patient co-variables in Gaucher disease: outcome of the Gaucher Earlier Diagnosis Consensus (GED-C) Delphi initiative. Intern Med J. 2019;49:578-91.

8. Roh J, Subramanian S, Weinreb NJ, Kartha RV. Gaucher disease - more than just a rare lipid storage disease. J Mol Med. 2022;100:499-518.

9. Nalysnyk L, Rotella P, Simeone JC, Hamed A, Weinreb N. Gaucher disease epidemiology and natural history: a comprehensive review of the literature. Hematology. 2017;22:65-73.

10. Wang M, Li F, Zhang J, Lu C, Kong W. Global epidemiology of Gaucher disease: an updated systematic review and meta-analysis. J Pediatr Hematol Oncol. 2023;45:181-8.

11. Castillon G, Chang SC, Moride Y. Global incidence and prevalence of Gaucher disease: a targeted literature review. J Clin Med. 2022;12:85.

12. Lepe-Balsalobre E, Santotoribio JD, Nuñez-Vazquez R, et al. Genotype/phenotype relationship in Gaucher disease patients. Novel mutation in glucocerebrosidase gene. Clin Chem Lab Med. 2020;58:2017-24.

13. Ormazabal ME, Pavan E, Vaena E, et al. Exploring the pathophysiologic cascade leading to osteoclastogenic activation in Gaucher disease monocytes generated via CRISPR/Cas9 technology. Int J Mol Sci. 2023;24:11204.

14. Revel-Vilk S, Szer J, Zimran A. Hematological manifestations and complications of Gaucher disease. Expert Rev Hematol. 2021;14:347-54.

15. Thomas AS, Mehta A, Hughes DA. Gaucher disease: haematological presentations and complications. Br J Haematol. 2014;165:427-40.

16. Cappellini MD, Motta I, Barbato A, et al. Similarities and differences between Gaucher disease and acid sphingomyelinase deficiency: an algorithm to support the diagnosis. Eur J Intern Med. 2023;108:81-4.

17. Yoshimitsu M, Ono M, Inoue Y, Sagara R, Baba T, Fernandez J. Cross-sectional web-based survey among haematologists and gastroenterologists in Japan to identify the key factors for early diagnosis of Gaucher disease. Intern Med J. 2023;53:930-8.

18. Biegstraaten M, Cox TM, Belmatoug N, et al. Management goals for type 1 Gaucher disease: an expert consensus document from the European working group on Gaucher disease. Blood Cells Molec Dis. 2018;68:203-8.

19. Luettel DM, Terluk MR, Roh J, Weinreb NJ, Kartha RV. Emerging biomarkers in Gaucher disease. In: Makowski GS, Editor. Advances in Clinical Chemistry. London UK, Elsevier; 2025. pp. 1-56.

20. Rosenbloom BE, Cappellini MD, Weinreb NJ, et al. Cancer risk and gammopathies in 2123 adults with Gaucher disease type 1 in the International Gaucher Group Gaucher Registry. Am J Hematol. 2022;97:1337-47.

21. Harvey AM, Barondess JA, Bordley J. Differential diagnosis: the interpretation of clinical evidence. 3th ed. Philadelphia: Saunders, 1979. Available from: https://catalog.nlm.nih.gov/discovery/fulldisplay/alma995164033406676/01NLM_INST:01NLM_INST [accessed 22 December 2025].